A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma.
about
Regional therapies for in-transit diseaseCurrent trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.Effects of hyperthermia on the peripheral nervous system: a review.Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.History of regional chemotherapy for cancer of the extremities.Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI.Future directions in regional treatment strategies for melanoma and sarcoma.Murine portal vein catheterization to analyze liver-directed therapies.Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?Predicting disease progression after regional therapy for in-transit melanoma.Optimizing regional infusion treatment strategies for melanoma of the extremitiesPharmacotherapy of regional melanoma therapy.Regional treatment strategies for in-transit melanoma metastasis.Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.Isolated limb perfusion for malignant melanoma.Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanomaPatterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.Laparoscopic hyperthermic isolated limb perfusion a new minimally invasive approach for HILP.The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.
P2860
Q28087553-70F4804A-376C-46D1-955E-F2F79633CD70Q35127039-A6769BDF-27E4-48EA-BC22-5DEDA6041DE1Q35809599-BCC1A87E-B51C-472F-9315-802B144F5437Q35861663-B95FA83E-70E5-4A32-B1E0-A0F235676DCAQ37130233-6CFDF033-96E6-4142-8D8F-97CC8ABE51D3Q37130246-69D2EFC9-CC91-4970-B5AD-82DA326F675CQ37130262-B838D5BD-9A05-4CB3-807A-21D1CEDF2667Q37315443-11D8E4B9-E253-4FA2-95E1-9DF17B4BBD90Q37414453-19F8B9C7-BB50-4A80-8272-3FEB475BFAE4Q37509683-25551D51-CFF9-4374-8F23-E8F5ED8DB009Q37628698-48B13602-7676-4E44-854E-7CC8640ACE9BQ37650312-3D543AB6-65FA-4501-901A-11CED8F606CBQ37812815-ECB50247-76E0-41A9-BCCB-7CD4DD67DF8DQ37943015-B28D597A-0EB5-4131-A8D3-7C992358852DQ41207379-D33C6E5F-3C42-44F7-A7E8-6BEE18D885ECQ41809290-42D8BD05-7A79-49A0-BB03-79C8E2860045Q42371514-5DF3881D-7928-43F1-A47A-6865F4F608E5Q44752180-10EDC251-5754-4DBE-B189-C2A1E96B5429Q47753790-81008709-6928-458A-9455-A933BDFF5E1BQ55041056-E01C7138-95A7-4438-9BC2-36A12D952C6A
P2860
A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@en
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@nl
type
label
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@en
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@nl
prefLabel
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@en
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@nl
P2093
P1433
P1476
A clinical and pharmacokinetic ...... at and melphalan for melanoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E
P407
P577
1985-06-01T00:00:00Z